Jasper Therapeutics’ anti-c-KIT antibody has shown promise in a Phase 1b/2a test in people with certain irritable skin conditions, sending its shares rising on Monday …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Pfizer’s diluted earnings per share saw a sharp decline to $0.01 from $0.41 in the same quarter of the previous year. Credit: Karolis Kavolelis/Shutterstock. Pfizer
By 2030, agreed a roomful of radiologists in Chicago this week, generative AI will be ubiquitous in their written work. Medical imaging already leads the
ST. LOUIS — Firefighter and paramedic Mike Camilleri once had no trouble hauling heavy gear up ladders. Now battling long Covid, he gingerly steps onto